Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Vassilopoulos

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Rheumatology (Oxford, England)|October 30, 2025
Comparable 12-month renal response outcomes with medium vs. high-dose starting prednisone in a real-world study of lupus nephritisMaria Pappa, Sofia Flouda, Antigone Pieta, et al.
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
Therapeutic Advances in Musculoskeletal Disease|October 16, 2020
Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patientsKonstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Annals of the Rheumatic Diseases|November 11, 2021
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseasesCharalampos Papagoras, George E Fragoulis, Nikoleta Zioga, et al.
Clinical Rheumatology|September 21, 2023
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseasesCharalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
European Journal of Preventive Cardiology|October 16, 2019
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) studyMassimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari, et al.
Rheumatology (Oxford, England)|December 9, 2020
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritisKonstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, et al.
Mediterranean Journal of Rheumatology|January 29, 2024
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisGeorge E Fragoulis, Charalampos Papagoras, Sousana Gazi, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Rheumatology (Oxford, England)|October 30, 2025
Comparable 12-month renal response outcomes with medium vs. high-dose starting prednisone in a real-world study of lupus nephritisMaria Pappa, Sofia Flouda, Antigone Pieta, et al.
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
Therapeutic Advances in Musculoskeletal Disease|October 16, 2020
Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patientsKonstantinos Thomas, Argiro Lazarini, Evripidis Kaltsonoudis, et al.
Annals of the Rheumatic Diseases|March 17, 2023
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 updateBernhard Hellmich, Beatriz Sanchez-Alamo, Jan H Schirmer, et al.
Annals of the Rheumatic Diseases|November 11, 2021
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseasesCharalampos Papagoras, George E Fragoulis, Nikoleta Zioga, et al.
Clinical Rheumatology|September 21, 2023
Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseasesCharalampos Papagoras, Nikoleta Zioga, Vasileios Papadopoulos, et al.
European Journal of Preventive Cardiology|October 16, 2019
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) studyMassimo Imazio, Alessandro Andreis, Gaetano Maria De Ferrari, et al.
Rheumatology (Oxford, England)|December 9, 2020
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritisKonstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, et al.
Mediterranean Journal of Rheumatology|January 29, 2024
Disease Profile and Achievement of Therapeutic Goals in a Modern, Nationwide Cohort of 923 Patients with Psoriatic ArthritisGeorge E Fragoulis, Charalampos Papagoras, Sousana Gazi, et al.
Pageof 17